Literature DB >> 2167785

Patients' perception of distress due to symptoms and effects of asthma on daily living and an investigation of possible influential factors.

F H Quirk1, P W Jones.   

Abstract

1. Distress ratings for questions relating to the symptoms and impacts of asthma on daily living have been examined in 40 adult asthmatic outpatients. 2. The patients responded to each item in a 76-item questionnaire by marking a 10 cm visual analogue scale to indicate the degree of distress associated with the symptoms or state described in the question. The resulting score (as a percentage of 10 cm) was interpreted as the degree of distress associated with a particular item. 3. The possible influence on these distress scores of five factors, age, duration (time in years from diagnosis to interview), variability [recorded variability of forced expiratory volume in 1 s (FEV1) expressed as amplitude per cent mean], sex and FEV1 (current and worst recorded in the clinic, expressed as per cent of predicted) was investigated. 4. From correlations of each item with age, 11/76 items were significant at P less than 0.05. Taking the results from all 76 items in a repeated measures analysis of variance, there was a small significant relationship between age and distress score (P = 0.048). The direction of the association was negative, suggesting that younger patients were less tolerant of asthma; however, the effect of age only explained 1.5% of the total variance in scores of the 76 items. 5. From correlations of visual analogue scale score for each item against duration, 10/76 items were significant at P less than 0.05, but taking the 76 items overall there was no significant association (P = 0.2). 6. The remaining factors, sex, variability and FEV1, only showed a significant effect in 1/76, 1/76 and 5/76 items, respectively (P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2167785     DOI: 10.1042/cs0790017

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  17 in total

1.  A new tool for monitoring asthma outcomes: the ITG Asthma Short Form.

Authors:  M S Bayliss; D M Espindle; D Buchner; M S Blaiss; J E Ware
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

2.  Asthma specific quality of life scale in a study of salmeterol hydroxynaphthoate.

Authors:  M E Hyland; G Coward; F Upchurch; K P Jones
Journal:  Br J Gen Pract       Date:  1991-05       Impact factor: 5.386

Review 3.  Quality of life measurement for patients with diseases of the airways.

Authors:  P W Jones
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

Review 4.  Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.

Authors:  H M Lamb; C R Culy; D Faulds
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

5.  Quality-of-life assessment in respiratory disease: an examination of the content and validity of four questionnaires.

Authors:  M E Hyland
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

Review 6.  Using subjective health assessments in practice and policy-making.

Authors:  G Albrecht
Journal:  Health Care Anal       Date:  1996-11

7.  Patient weighting of importance of asthma symptoms.

Authors:  L M Osman; L McKenzie; J Cairns; J A Friend; D J Godden; J S Legge; J G Douglas
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

8.  Impact of obstructive airways disease on quality of life in older adults.

Authors:  D S Renwick; M J Connolly
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

9.  Predicting patient attitudes to asthma medication.

Authors:  L M Osman; I T Russell; J A Friend; J S Legge; J G Douglas
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

10.  Measurement of the validity and reliability of the persian translation of the saint george respiratory questionnaire for patients with chronic obstructive pulmonary disease.

Authors:  Saeid Fallah Tafti; Ali Cheraghvandi; Mehran Marashian; Habib Emami; Bahareh Mokri
Journal:  Open Respir Med J       Date:  2009-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.